Lakeshore Biopharma CO (LSBCF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2025 | 03-2024 | 03-2023 | 12-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 14,974 | 34,750 | 53,898 | 885 | N/A |
| Receivables | 69,783 | 62,602 | 67,385 | N/A | 0 |
| Inventories | 31,706 | 28,671 | 26,978 | N/A | 0 |
| Other current assets | 235 | 234 | 984 | 0 | 0 |
| TOTAL | $117,330 | $127,296 | $150,760 | $1,027 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 57,605 | 66,716 | 83,205 | N/A | 0 |
| Investments And Advances | 0 | 0 | 0 | 200,007 | 0 |
| Intangibles | 10,149 | 10,042 | 11,359 | 0 | 0 |
| Other Non-Current Assets | 5,446 | 9,199 | 4,942 | 0 | 0 |
| TOTAL | $73,200 | $85,956 | $99,506 | $200,007 | $N/A |
| Total Assets | $190,530 | $213,253 | $250,266 | $201,034 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 54,393 | 44,897 | 28,193 | N/A | 0 |
| Accounts payable and accrued liabilities | 6,903 | 9,553 | 11,706 | 0 | 0 |
| Accrued Expenses | 53,335 | 57,609 | 54,941 | 143 | N/A |
| TOTAL | $114,897 | $113,069 | $95,866 | $143 | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,274 | 13,951 | 42,754 | N/A | 0 |
| Deferred Revenues | 203 | 284 | 334 | N/A | N/A |
| Other Non-Current Liabilities | 480 | 893 | 2,204 | 20,209 | 0 |
| TOTAL | $6,012 | $17,702 | $48,393 | $20,209 | $N/A |
| Total Liabilities | $120,909 | $130,771 | $144,258 | $20,352 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | N/A | 9,306 | N/A | N/A |
| Common Shares | 4 | 4 | 2 | 200,001 | N/A |
| Retained earnings | -335,388 | -325,229 | -272,718 | -19,318 | N/A |
| Other shareholders' equity | -7,979 | -8,200 | -7,918 | 0 | 0 |
| TOTAL | $69,621 | $82,482 | $106,008 | $180,682 | $N/A |
| Total Liabilities And Equity | $190,530 | $213,253 | $250,266 | $201,034 | $0 |